Last week the IAAF amended their classification for “female of intersex (or equivalent)” athletes with elevated blood testosterone levels, applying to those competing in the 400m, 800m, 1,500m, mile and 400m hurdles.
The new ruling, due to come into effect on November 1, is widely expected to affect star South African athlete Caster Semenya.
Gideon Sam, president of Sascoc, welcomed the ASA’s decision to challenge the IAAF, and if required, take its case to the Court of Arbitration for Sport (CAS).
“As the parent body of our member federations, we needed to take the lead from ASA in this case and are fully supportive of their decision to engage with athletics’ governing body, the IAAF, going forward. We were deeply disappointed when the IAAF made their ruling, and we simply can’t stand back and allow Caster’s name to be dragged through the publicity mill yet again. The protection of our athletes and their dignity is of utmost importance.
“We continue to produce high quality sportsmen and women and as the mother body to ASA, we can assure them that they have our backing all the way,” Sam added.
Sascoc will engage with both ASA and its HP Commission to conduct a detailed analysis into the ruling and the debate around it.
The process is already at a stage where the Sascoc HP Commission is putting together a group of experts, chaired by the Sascoc Medical Commission, to drive this process and advise its board.
Phatho Zondi is the chairperson of Sascoc’s Medical Commission and a proposal to establish an advisory committee has been supported.
The committee would comprise professionals that include a sports physician, legal council, endocrinologist, and sports scientist. The experts would investigate the IAAF ruling and provide advice to Sascoc on a proposed course of action going forward, with an understanding of the relative urgency of such an investigation.